It could also sell $180 million worth of Ateromixol per year if it just captured 1 per cent of the sales of cholesterol-reducing drugs in the United States.
古巴只要能占到美国降胆固醇药品销售量的1％，本来每年也可以向美国销售价值1.8亿美元的Ateromixol。